Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3α-reduced neurosteroids
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The central processing of peripheral nociceptive messages is highly controlled by the activity of local inhibitory networks in the spinal cord and supraspinal centers. Recently, it has been shown that endogenous 3alpha-reduced neurosteroids (3alphaNS) exert a significant spinal antinociception by potentiating GABA(A) receptor function. Because endogenous 3alphaNS can be produced in many relay structures of the nociceptive system, we tested the potential analgesic efficacy of promoting the production of neurosteroids by using etifoxine (ETX, 50mg/kg i.p.). This prescribed non-benzodiazepine anxiolytic was shown previously to stimulate neurosteroidogenesis in its early step after binding to the mitochondrial translocator protein complex (TSPO). Using an animal model of generalized neuropathic pain resulting from a 2-week treatment with the antitumoral agent vincristine sulfate (VCR, 0.1mg/kg i.p.), we show that injections of ETX (50mg/kg i.p.) given every day reduced the VCR-induced mechanical and thermal pain symptoms but also prevented their appearance, if used in prophylaxia 1 week before VCR. Both the curative and preventive effects of ETX on pain symptoms were mediated by the production of 3alphaNS as demonstrated in animals treated with the enzymatic inhibitor provera (6-medroxyprogesterone acetate; 20mg/kg s.c.). Altogether, this study shows for the first time that promoting 3alphaNS could be a possible therapeutic strategy to treat neuropathic pain symptoms. Since ETX is already available as an anxiolytic, its use in humans, provided that its analgesic properties are confirmed, could be rapidly considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159 · cited 5×
“This indirect effect leads to a prolonged increase in synaptic and extrasynaptic inhibition mediated by GABAARs.”
BackgroundInfluentialNeurosteroids: biosynthesis and function of these novel neuromodulators
Compagnone, N. A., & Mellon, S. H. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0188 · Cited by 820 · cited 1×
“Neurosteroids are initially synthesized from cholesterol in the mitochondria and further converted into active metabolites upon the action of various enzymes which are widely expressed in the central and peripheral nervous systems [7,21].”
BackgroundSivilotti, L., & Woolf, C. J. (1994) · Journal of Neurophysiology · doi:10.1152/jn.1994.72.1.169 · Cited by 468
Reversal of pathological pain through specific spinal GABAA receptor subtypes
Knabl, J., Witschi, R., Hösl, K., Reinold, H., Zeilhofer, U. B., Ahmadi, S., Brockhaus, J., Sergejeva, M., Hess, A., Brune, K., et al. (2008) · Nature · doi:10.1038/nature06493 · Cited by 438 · cited 1×
“of exogenous modulators targeting specific GABAARs within the nociceptive system [19], there are growing lines of evidence indicating that the antinociceptive properties of local endogenous neuroactive neurosteroids could be used as an alternative strategy [28].”
BackgroundWeng, R. H., Cordella, V. J., & Dougherty, M. P. (2003) · Pain · doi:10.1016/s0304-3959(02)00445-1 · Cited by 161 · cited 2×
“days 1–5 and days 7–11 with 2 days off) as previously described [38].”
MethodPain related behaviour during vincristine-induced neuropathy in rats
Authier, N., Coudore, F., Eschalier, A., & Fialip, J. (1999) · NeuroReport · doi:10.1097/00001756-199904060-00013 · Cited by 77 · cited 1×
“In the present work, we aimed at evaluating the possible use of ETX in both curative and/or preventive treatments in the vincristine sulfate (VCR) model of chemotherapy-induced neuropathy in rats [1,38].”
Method
Cited by
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
Understanding Emotions: Origins and Roles of the Amygdala
Šimić, G., Tkalčić, M., Vukić, V., Mulc, D., Španić, E., Šagud, M., Olucha-Bordonau, F. E., Vukšić, M., & R. Hof, P. (2021) · Biomolecules · doi:10.3390/biom11060823 · Cited by 503
Anxiety disorders and GABA neurotransmission: a disturbance of modulation
Gauthier, I., & Nuss, P. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s58841 · Cited by 466
Schumacher, M., Mattern, C., Ghoumari, A., Oudinet, J. P., Liere, P., Labombarda, F., Sitruk-Ware, R., De Nicola, A. F., & Guennoun, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 355
Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa
Girard, C., Liu, S., Adams, D., Lacroix, C., Sinéus, M., Boucher, C., Papadopoulos, V., Rupprecht, R., Schumacher, M., & Groyer, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02215.x · Cited by 75
Metadata
- Authors
- Aouad, M., Charlet, A., Rodeau, J.-L., & Poisbeau, P.
- Venue
- Pain
- Published
- 2009-12
- Volume
- 147
- Issue
- 1
- Pages
- 54-59
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2050292907
- Cited by
- 47
- References
- 6
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3α-reduced neurosteroids. https://app.cochat.ai/papers/10.1016/j.pain.2009.08.001
- The paper
- Aouad, M., Charlet, A., Rodeau, J.-L., & Poisbeau, P. (2009). Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3α-reduced neurosteroids. Pain. https://doi.org/10.1016/j.pain.2009.08.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.